These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6611299)

  • 1. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The low affinity 40,000 Fc gamma receptor and the transferrin receptor can be alternative or simultaneous target structures on cells sensitive for natural killing.
    Perl A; Looney RJ; Ryan DH; Abraham GN
    J Immunol; 1986 Jun; 136(12):4714-20. PubMed ID: 3011902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of responses measured by natural cytotoxicity and chemiluminescence.
    Ernst M; Lange A; Flad HD; Havel A; Ennen J; Ulmer AJ
    Eur J Immunol; 1984 Jul; 14(7):634-9. PubMed ID: 6430710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukemia-derived cell lines and clones as models for mechanistic analysis of natural killer cell-mediated cytotoxicity.
    Zarcone D; Tilden AB; Friedman HM; Grossi CE
    Cancer Res; 1987 May; 47(10):2674-82. PubMed ID: 2436754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation.
    Hagner G
    Immunobiology; 1984 Oct; 167(4):389-97. PubMed ID: 6595216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism.
    Brahmi Z; Bray RA; Abrams SI
    J Immunol; 1985 Dec; 135(6):4108-13. PubMed ID: 3864859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a human natural killer cell target cell antigen with monoclonal antibodies.
    Harris DT; Jaso-Friedmann L; Devlin RB; Koren HS; Evans DL
    J Immunol; 1989 Jul; 143(2):727-35. PubMed ID: 2738407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to natural killer cell-mediated cytolysis by a pleiotropic drug-resistant human erythroleukemia (K562-R) cell line.
    Yanovich S; Hall RE; Weinert C
    Cancer Res; 1986 Sep; 46(9):4511-5. PubMed ID: 2425955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2.
    Blanchard DK; Stewart WE; Klein TW; Friedman H; Djeu JY
    J Immunol; 1987 Jul; 139(2):551-6. PubMed ID: 3496384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood.
    Freundlich B; Trinchieri G; Perussia B; Zurier RB
    J Immunol; 1984 Mar; 132(3):1255-60. PubMed ID: 6693767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
    Rönnblom L; Ramstedt U; Alm GV
    Eur J Immunol; 1983 Jun; 13(6):471-6. PubMed ID: 6574913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-activated NK cells trigger monocyte oxidative metabolism.
    Pohajdak B; Gomez JL; Wilkins JA; Greenberg AH
    J Immunol; 1984 Nov; 133(5):2430-6. PubMed ID: 6434630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.